XGN - exagen.com Operating income before deduction of amortization

Public company logo of exagen.com (XGN)

Exagen Inc. generates revenue through the implementation of unique laboratory tests designed to identify complex inflammatory pathologies. The company's estimated EBITDA reflects actual cash flow, while 0.00 captures the current state of the parameter. Growth is driven by the rollout of AVISE genomic tests, although final profitability is constrained by strict insurance reimbursement policies and limited pricing power.

Operating profit EBITDA: Exagen (XGN) for 11/23/2025 - 11/12/2026

Exagen (XGN) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Market Chart Exagen Inc|XGN - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Exagen Inc.|XGN - Total Company Value
- balance sheet equity data:
Net Assets per Share Exagen Inc.|XGN - Book Capitalization|Market-to-Book Ratio exagen.com|XGN - Cumulative Company Assets
- debt level and financial liquidity data:
Debt to Equity Ratio Exagen Inc.|XGN - Long-Term Debt to Capital|Short-Term Debt to Capital Exagen Inc|XGN - Company Aggregate Debts|Debt to Net Assets Exagen Inc.|XGN - Company Long-Term Debts|Short-Term Debt Exagen Inc.|Immediate Liquidity Ratio exagen.com
- company profitability and valuation multiples indicators:
XGN - Net Income|Expected Net Income Exagen Inc.|XGN - P/E Multiple|Market Cap to Projected Earnings Exagen Inc|XGN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Exagen Inc.|XGN - Operating profit EBITDA|Net earnings per share for the last 12 months Exagen Inc.|XGN - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months exagen.com|XGN - Net earnings per share growth this year|Projected earnings per share growth rate for next year Exagen Inc.
Summary company analytics:XGN, Exagen Inc.
Flagship merchandise of Exagen

Investors are assessing the resilience of Exagen Inc. (XGN) through operating cash flow, excluding the impact of depreciation and taxes to identify the net scaling rate of the business. An analysis of historical EBITDA_Co data, with a current value of 0.00, confirms the efficiency of cloud outsourcing for medical data storage, where infrastructure cost optimization and strict SLAs translate directly into operating profit growth.

Who Exagen Inc. competes with

Operating income before deduction of amortization Agilent Corp (A)|Quest Diagnostics - Operating profit EBITDA|Operating income before deduction of amortization illumina.com ILMN|Exact Sciences Corporation (EXAS) - Profit before payment of interest, taxes and amortization|RVTY - Operating income before deduction of amortization|BIO (Bio-Rad Laboratories Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Anbio Corp NNNN|Operating profit before deduction of amortization SHC (Sotera Health Company)|quidel.com - Operating profit before amortization|Operating profit EBITDA OPK (OPKO Health)|Operating profit EBITDA CareDx Corp CDNA|Maravai LifeSciences Corp - Operating profit EBITDA|Operating profit before depreciation charges Fulgent (FLGT)|LAB: Operating profit EBITDA|Profit before interest, taxes and amortization cytekbio.com (CTKB)|Profit before payment of interest, taxes and amortization OraSure|Operating profit before amortization MDXH (MDxHealth S.A.)|Operating profit before deduction of amortization LUCD (Lucid Diagnostics Inc)|PRE (prenetics.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA IMDX (Insight Molecular Diagnostics Inc)|Operating income before deduction of amortization Trinity Biotech PLC (TRIB)|PRPH - Profit before payment of interest, taxes and amortization|AIMD (Ainos Inc) - Operating profit before amortization|CODX: Operating profit EBITDA|Operating profit before deduction of amortization Heart Test Labs|Operating profit before deduction of amortization BMRA|Cardio Diagnostics Holdings, Inc. (CDIO) - Operating income before deduction of amortization|Operating profit before deduction of amortization ONCO (Onconetix)|Virax Biolabs Group Limited - Operating profit before amortization|Operating profit EBITDA BJDX (Bluejay)|Operating profit before depreciation charges Aspira Women's Health Inc|AXDX - Profit before payment of interest, taxes and amortization|CNTG (Centogene) - Operating profit before amortization|enzo.com (ENZ) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Fresh2 Group|GENE (Genetic Technologies Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization 23andMe Inc ME|Operating profit EBITDA PMD